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ABSTRACT 
 
Floor plate cells of the mesencephalon have the ability to become more floor plate 
cells or differentiate into dopamine containing neurons. Maturation of these neurons can 
be marked by the stage of differentiation. When dopamine neurons of the substantia nigra 
pars compacta are no longer able to communicate with the corpus striatum due to a 
marked loss in the neurotransmitter dopamine, movement disorders such as those present 
in Parkinson’s disease occur. The bHLH transcription factor Nato3 is known to be 
necessary for normal dopamine neuron formation, however, our lab was interested in its 
sufficiency to drive a dopaminergic lineage. The aim of this study was to begin to 
understand the molecular mechanisms responsible for dopamine neurogenesis in order to 
understand therapeutic means that may help combat Parkinson’s disease when these 
dopamine neurons are lost. Overexpression of Nato3 as well as cofactor combinations 
(Otx2, Foxa2 and Lmx1a) was performed using in ovo electroporation and a fast 
screening method of qPCR was implemented in order to screen multiple genes that may 
be involved in the production of dopamine (Nurr1, Pitx3 and TH). Unfortunately, due to 
variability and inconsistencies of the electroporation efficiency and the low magnitude of 
change in marker expression, it is inconclusive as to whether or not Nato3 is sufficient to 
drive dopamine neurogenesis. Multiple approaches to improve the variability in the 
methods are addressed. 
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CHAPTER I 
 
Introduction 
 
The Neural Tube 
During development, the nervous system arises from a structure known as the 
neural tube that differentiates along the rostral-caudal axis to form the telencephalon (the 
forebrain) at the rostral pole, the diencephalon (includes deep brain structures like the 
thalamus), the mesencephalon (where dopamine neurons arise), the hindbrain and the 
spinal cord (the portion caudal to the hindbrain) (Placzek and Briscoe 2005).  Dopamine 
(DA) neuron progenitors arise from a specific region along the ventral midline of the 
developing mesencephalon, known as the floor plate (Figure 1A). These progenitors can 
then differentiate into dopaminergic neurons that occupy the substantia nigra and ventral 
tegmental regions of the mesencephalon (Olanow et al., 2009). Although the floor plate is 
a region of the ventral neural tube that extends caudally from the diencephalon to the 
spinal cord, it only gives rise to DA neurons specifically in the mesencephalon.   
 
Mesencephalic Floor Plate Cells 
A characteristic of floor plate cells in the mesencephalon, as well as all other 
regions, is that they release the morphogen Sonic hedgehog (Shh), which influences the 
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neural fate of neighboring neural progenitors locally and distally in the neural tube 
(Briscoe and Novich 2008). They also release Netrins, which are critical for axon 
guidance of commissural neurons that cross the midline at the floor plate (Charron et al., 
2003, Colamarino et al., 1995).  There are two important types of floor plate cells, those 
that reside medially, along the ventral midline of the neural tube, and those that lie more 
laterally, adjacent to the most medial population. Secretion of Shh from the notochord is 
initially responsible for floor plate cell specification through induction of Foxa2 
(Mansour et al., 2011). Maintenance of that secretion over time allows in part for the 
conversion of neural epithelial cells into floor plate cells or into other ventral neural 
progenitors (Ribes et al., 2010). Mesencephalic floor plate (mesFP) cells have been 
proposed to give rise to DA neurons. Differentiation of neural progenitors in the floor 
plate in the midbrain is due to two important events. Persistent expression of Shh causes a 
decrease in neurogenesis, but a factor in the midbrain known as Wnt1 has a temporally 
specific antagonist effect on Shh that allows for neurogenesis (Joksimovic et al., 2009). 
MesFP cells continue to receive Shh signalling until shortly prior to exiting the cell cycle, 
where they are fated either to become dopamine containing neurons in the adult 
mesencephalon or regenerate the population of mesFP cells (Andersson et al., 2006, Ono 
et al., 2007, Kittappa et al., 2007).  
 
Dopamine neurogenesis and Parkinson’s disease 
Midbrain dopaminergic neurons produce an important chemical messenger, 
known as dopamine, and have cell bodies that reside in an area of the midbrain known as 
the substantia nigra pars compacta (SNpc) and the ventral tegmental area (Brodski et al., 
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2003). When the neurons of the SNpc die or become impaired the dopamine neurons can 
no longer transmit signals between the SNpc and the corpus striatum. Normally, the 
signalling between the SNpc and the striatum contributes to the motor programming that 
allows smooth, purposeful movement as well as controls cognition and emotional 
behavior (Nunes et al., 2003). However, loss of dopamine signalling due to destruction or 
disruption of these cells results in abnormal nerve firing patterns within the brain that 
cause impaired movement (Omodei et al., 2008, Thomas, 2010). Therefore, 
understanding the molecular cues that promote differentiation of dopamine neurons in the 
midbrain will aid in advancing the understanding of how these types of neurons are lost 
in Parkinson’s disease and what therapeutic methods can be implemented to combat this 
loss. 
As mentioned, mesFP cells can differentiate into dopamine containing neurons, a 
lineage that can be marked by the stage of cell differentiation (Figure 1B). Common 
markers used in this study are Nurr1, TH, and Pitx3. Nurr1 is known to regulate the 
differentiation of mesDA neurons and used as a marker for immature dopamine neurons 
(Nunes et al., 2003). Tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine 
production, is responsible for catalyzing the conversion of L-tyrosine into L-DOPA, a 
precursor for neurotransmitters. It is found within the cytosol of all cells that contain 
catecholamines and thus used as a marker for mature dopamine neurons (Haavik et al 
1998). Finally, Pitx3 is a protein required to differentiate dopamine neurons in the 
mesDA system and is commonly used as a marker for mature dopamine neurons in the 
substantia nigra (Smits et al., 2006, Nunes et al., 2003). 
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Nato3 
At all axial levels of the floor plate, a basic helix-loop-helix protein, Nato3 (also 
known as Ferdl3 or N-twist), is expressed during development. It has been shown that 
bHLH genes play an important role in neural development (Segev et al., 2001, Bertrand 
et al., 2002, Kageyama et al., 2005). Nato3 is important for normal DA neuron formation 
as demonstrated by previous studies involving a mouse knock out model where a deletion 
of the Nato3 gene showed a reduction in the number of DA neurons by 50% (Ono et al., 
2010). Based on our lab’s preliminary data, it is suggested that overexpression of Nato3 
in the chick embryo is sufficient to promote the expression of dopamine neuron markers 
in the posterior midbrain (caudal ventral midbrain) but not in any other region of the 
midbrain or neural tube. This regional specificity suggests that factors specific to the 
region are important for Nato3 action and thus we believe that there may be other 
cofactors in this region acting with Nato3 to induce dopamine neurogenesis. 
 
Nato3 controls Hes1 expression 
The action of Nato3 in the developing nervous system is believed to be mediated 
in part by its repression of Hes1 expression, a bHLH transcription factor known to 
suppress proneural gene expression (such as Ngn2 and Ascl1) (Kageyama et al., 2009). 
Proneural genes are required for the selection of progenitor differentiation to a particular 
lineage and induction of cell cycle arrest. For example, Ngn2 is essential for the 
differentiation of Nurr1 positive postmitotic mesDA neurons (Andersson et al., 2006) and 
induction of Ngn2 is observed in a subset of Nato3 positive cells (Ono et al., 2010). Prior 
to neurogenesis, the neural epithelium expresses Hes genes broadly, thus inhibiting 
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sustained proneural expression. During neurogenesis, sustained Hes1 gene expression 
typically inhibits proliferation of neural progenitors by G1 phase obstruction and 
blocking proneural gene transcriptional machinery (Kageyama et al., 2009). Repression 
of Hes1, such as through the expression of Nato3, could promote neurogenesis. 
At the onset of neurogenesis in the midbrain, Hes1 expression has been found to 
decrease in the mesFP region, however, Hes1 does not appear to be downregulated as 
much in the caudal floor plate (Ono et al., 2010). This expression suggests that Hes1 
suppression corresponds to the onset of neurogenesis. During neurogenesis, Hes1 gene 
expression is transiently inhibited, permitting proneural genes to drive neuronal 
differentiation. Interestingly, knock out of Nato3 was shown to cause ectopic expression 
of Hes1 in the mesFP (Ono et al., 2010). It was also determined that Nato3 suppresses 
Hes1 expression in floor plate cells regardless of their neurogenic activity and 
anterior/posterior location (Ono et al., 2010). Taken together, these data indicate that 
Nato3 could act to promote neurogenesis through suppression of Hes1 (Figure 2A). 
Although it is known that Hes1 must be repressed in order to induce neurogenic potential 
of mesFP cells, suppression of Hes1 is insufficient to attain full neurogenic potential of 
mesFP cells alone (Ono et al., 2010). It is more likely that that other midbrain factors 
coordinate with Nato3. This leads to the idea that Nato3 may regulate other pathways that 
are selective to controlling neurogenesis in mesFP cells, such as Otx2 control of the 
Lmx1a-Msx1/2 pathway, or Foxa2 independent regulation of proneural genes (Ono et al., 
2010) (Figure 2B). Therefore, determination of what other factors such as Otx2, Foxa2 or 
Lmx1a are required to induce neurogenic potential on mesFP cells when combined with 
Nato3 can yield insight into how these dopamine neurons are generated. These insights 
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may aid in the development of therapeutic approaches, such as stem cell therapies, or in 
understanding the pathogenesis of some forms of Parkinson’s disease that may arise from 
a defect in one of these genes. 
 
Possible cofactors 
There are multiple candidate genes that could serve as regionally specific 
cofactors to promote Nato3 neurogenesis in the midbrain, but a few, Otx2, Lmx1a, and 
Foxa2 are good candidates due to their known critical roles in regulating DA 
neurogenesis and expression in the same region as Nato3 (Ono et al., 2007, Ono et al., 
2010, Andersson et al., 2006, Ferri et al., 2007, Kittappa et al., 2007).  
 Otx2 is a transcription factor required for specification of mesDA progenitors 
(Omodei et al., 2008) with expression that is restricted to areas anterior to the 
midbrain/hindbrain boundary (Ono et al., 2007), and endogenous Otx2 expression is 
coexpressed with Nato3 in the floor plate region and is also seen in regions that flank the 
floor plate. Published data of genetic “knock out” mouse models have also shown that 
Otx2 is required for mesDA neuron development (Puelles et al., 2004). A study 
performed by Ono et al., (2007) showed that ectopic expression of Otx2 in caudal floor 
plate cells (hindbrain), an area which is normally not neurogenic, were positive for the 
mature DA neuron marker tyrosine hydroxylase (TH). Interestingly, Nato3 is also 
endogenously expressed in the floor plate region of both the hindbrain as well as the 
midbrain (Ono et al., 2010).  Therefore, it is possible the DAergic action of Otx2 
hindbrain floor plate could be due to the presence of endogenous Nato3.  Thus 
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coexpression of Nato3 and Otx2 within the same cell may be sufficient for generating a 
greater percentage of neuron progenitor cells in neural progenitors.   
A second candidate cofactor that may help promote Nato3 action in the midbrain 
is Lmx1a. Like Nato3, Lmx1a regulates neurogenesis through repression of Hes1 (Yan et 
al., 2011). Lmx1a is also coexpressed with Nato3 in floor plate cells in all ventral midline 
cells in the mesencephalon and is specific to the floor plate region of the mesencephalon 
(Andersson et al., 2006), whereas other factors such as Otx2 and Foxa2 are expressed 
more broadly (Ono et al., 2007, Patten et al., 2003). The importance of Lmx1a in DA 
neurogenesis is further supported by an Lmx1a knockout in the mouse embryo, which 
showed that the number of TH+ cells was eliminated at the ventral midline in comparison 
to the wild type (Andersson et al., 2006). Furthermore, when Lmx1a was overexpressed 
in the midbrain of the chick embryo, there was found to be a dramatic increase in the 
number of DA neurons (Andersson et al., 2006). However, Lmx1a promotion of DA 
neurogenesis was only seen in the ventral midbrain, in the same region that Nato3 is 
expressed (Ono et al., 2010). This suggests that Nato3, or another factor with similar 
restricted expression in the ventral midbrain, is responsible for the effect of Lmx1a. 
 The expression of Foxa2 (aka HNF3ß), the final candidate of interest, is a 
transcription factor required for development and maintenance of mesDA neuron 
development (Ferri et al., 2007, Kittapa et al., 2007). Foxa2 is found to be initially 
restricted to the floor plate region in the central nervous system; however, it spreads 
laterally beyond the borders of the floor plate into the ventral midbrain (Patten et al., 
2003). A genetic deletion of Foxa2 in a mouse model revealed that having one copy of 
the Foxa2 gene showed a lack of TH+ cells and motor deficits that showed some 
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similarity to those observed in Parkinson’s patients (Ferri et al., 2007). This would 
indicate that Foxa2 might play a role in regulating the response of DA neurons to 
oxidative stress (Kittappa et al., 2007). It has also been noted that Foxa2 may have 
multiple roles in the developing nervous system; one being that overexpression of Foxa2 
can lead to an increase in the number of TH+ cells observed (Nakatani et al., 2010). More 
recently, it has been suggested that Foxa2 is a direct upstream regulator of Nato3 and that 
there are two Foxa2 conserved binding sites within the promoter of a conserved element 
with patterning that mimics Nato3 endogenous expression (Mansour et al., 2011). 
 
Current Study 
 Not all regions of the nervous system are competent to give rise to DA neurons 
when Nato3, Otx2, Lmx1a, and Foxa2 are overexpressed. It is apparent that each gene 
cannot be the only factor important in the generation of DA neurons, suggesting a 
combination of these genes, acting as cofactors, may be sufficient for DA neurogenesis.  
In addition to analyzing the capacity of Nato3 in the generation of a dopamine lineage, a 
second objective was to investigate this possible overexpression of these cofactors and 
the effects they may have on dopamine neurogenesis. In order to show this we aimed to 
devise an appropriate method to be able to quickly screen the efficiency of the cofactor 
combination in vivo through the use of qPCR. If this approach of using qPCR as a fast 
screening method is successful, it would allow for combinations of cofactors and 
conditions to be assayed more quickly and more broadly than using an anatomical 
approach. It may also allow for monitoring of genes that may have an indirect effect on 
key markers that are found to be involved in dopamine neurogenesis.  
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CHAPTER II 
 
Results 
 
Efficiency testing and Statistical Analysis 
Efficiency tests were conducted on all four primers using three different 
concentrations (10, 100, 1000 ng) of template DNA to generate a standard curve. A no 
template control (NTC) was also included to ensure that there are no contaminants 
present in the sample. When a primer has an efficiency of 100% it corresponds to 
doubling of the DNA for each cycle. The β-actin, Nurr1, Pitx3 and TH primers were 
designed against the Gallus gallus gene as described in Chapter 2 (Methods). These 
samples were run on the Mx3000P software using SYBR Green. Percentage of efficiency 
was calculated using: Efficiency = 10^ (-1/slope)-1, where the slope should be between -
3.10 and -3.59 (Pfaffl, 2001). Fold change could then be calculated using the slope. 
Having an efficiency of 100% would indicate that there is a 2-fold difference in the 
cycles, with the crossing threshold (Ct) value being determined from a log-linear plot of 
the signal versus the cycle number (Livak et al., 2001). Change in expression levels of a 
gene between two conditions is determined by comparing the Ct values. A gene with 
higher levels of expression should in theory show up faster than the control. We were 
interested in the relative differences between samples as demonstrated by a fold 
difference on the y-axis. 
The efficiency of ß-actin was calculated to be 81% with a 1.84 fold increase for a 
2 fold difference (Figure 4A), Nurr1 was calculated to be 97.6% with 1.98 fold increase 
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(Figure 4B), TH was calculated to be 143% with 2.43 fold increase (Figure 4C), and 
Pitx3 was calculated 103% with 2.03 fold increase (Figure 4D).  
Differences in efficiency within primers can occur due to factors such as primer 
dimer and hairpin structures, however, variation between 90-110% is considered to be 
sufficient. TH for example, has an efficiency that is considered too high and likely due to 
primer dimers appearing at low levels of cDNA. This primer was still used since the 
focus was placed on Nurr1 and since we are using the qPCR as a fast screening method. 
ß-actin was determined to have a lower percent efficiency than we would have liked to 
have, meaning that it may underestimate the potential changes in template concentration. 
Unfortunately, the Gallus gallus β-actin is still listed as provisional and the primers that 
were generated had the least amount of primer dimers and hairpin structures that were 
available. Future studies will need to attempt to design other primers against ß-actin and 
other housekeeping genes to expand primer options and make comparisons to the one 
used in this experiment. 
 
Statistical analysis using two different comparative methods 
 Efficiency calculations were used to account for differences in some analyses for 
significance, including the Pfaffl method of REST analysis (described in methods). This 
study incorporated two methods to analyze for significance between the test and control 
samples for every set of data points. The ddCt method is one of the most common 
analysis tools to compare relative expression results (Pfaffl, 2001), however, its 
limitations lie in presuming the efficiency of the target and reference gene to be the same. 
A new method called REST analysis was presented as a way to account for a difference 
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in primer efficiency and still be able to calculate error (Pfaffl, 2001, Pfaffl et al., 2002). 
The software is designed to compare a test and control group for significance using 
randomization testing of group-wise calculation of the relative expression (Pfaffl et al., 
2002). Given that the primer efficiencies of β-actin, Nurr1, Pitx3, and TH were not 
100%, we chose to compare the two methods. Unfortunately, one of the limitations to the 
REST software is the inability to input an efficiency of >100%. This allowed us to only 
be able to compare Nurr1 sample sets (97.6%) since TH and Pitx3 were greater than 
100% efficiency with 143% and 103% respectively.  
 
Overexpression of Nato3 on DA neuron lineage marker expression in ovo 
We began experiments with a sample set of n=3 for both Nato3 overexpression 
and pCIG. Figure 6 shows a comparison of fold change derived either from the standard 
ddCt method (Figure 6A) or Pfaffl’s REST analysis (Figure 6B). The ddCt method 
showed a 2.6 fold increase in Nurr1 mRNA expression in comparison to the control, and 
similarly the REST analysis showed a 2.50 fold increase. REST analysis could not 
applied to Pitx3 and TH primers due to over efficiency of the primers and the 
assumptions the REST analysis required in its calculations of the software, therefore only 
the ddCt method was used. Figure 6C shows a 1.29 fold increase in Pitx3 mRNA 
expression, and Figure 6D shows a decrease in expression of 0.19 for TH in comparison 
to the control. Results of this experiment were not significant but promising considering 
our proposed role of Nato3 in dopamine neurogenesis and our observation of increased 
Nurr1 expression in the posterior caudal midbrain. Encouraged by these results, we 
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wanted to confirm published dopamine neurogenesis of known genes (Otx2, Foxa2 and 
Lmx1a) and make comparisons to Nato3 overexpression. 
 
Overexpression of known dopaminergic genes Otx2, Foxa2 and Lmx1a on DA neuron 
lineage marker expression 
 Previously published data on Otx2, Foxa2, and Lmx1a demonstrate that they are 
required for dopamine progenitor differentiation (Puelles et al. 2004, Andersson et al., 
2006, Ferri et al., 2007, Kittappa et al., 2007) in the mouse developmental system. In 
order to confirm that the same results are relevant to the chick development system we 
overexpressed them in the midbrain and compared expression to that of the pCIG control. 
Figure 7 shows a comparison of the ddCt method and Pfaffl’s REST analysis for the 
effect of overexpression of Otx2, Lmx1a, and Foxa2 on Nurr1 mRNA expression. Fold 
change of Nurr1 mRNA expression is similar between both methods and no significance 
is seen for any of the genes, however, the calculations of error are different between both 
forms of analysis and in turn measure variability differently. Overexpression of Otx2 and 
Foxa2 generated similar fold increase in Nurr1 of just under 2 fold, and Lmx1a 
expression was similar to the control (Figure 7). Similar results for Pitx3 were seen for 
Otx2 and Lmx1a in terms of their expression in comparison to Nurr1; however, Foxa2 
overexpression caused a 3.30 fold increase of Pitx3 when Foxa2 was overexpressed. 
Significance in this case was found at p <0.037 using a t-test, and confirmed with a non-
parametric Wilcoxon signed ranks test with significance at p<0.05 (Figure 8). This result 
should be replicated, but suggests that markers for DA neurons can be induced in the 
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developing chick midbrain with our electroporation method. Overexpression of all genes 
showed a decrease in TH in comparison to the control (Figure 9). 
 Interestingly, overexpression of Nato3 demonstrated a stronger trend of elevating 
DA lineage markers than the known dopaminergic genes with the exception of Pitx3 
when Foxa2 was overexpressed (Figure 7-9). This indicates that Nato3 may be important 
in the generation of mesDA neurons. Unfortunately, results obtained were not as 
significant at p <0.05 as those presented in literature. Although most results were not 
significant in concluding that Otx2, Foxa2 and Lmx1a may play the same role in the 
chick development system, we directed focus to whether coexpression of these genes and 
Nato3 would produce a significant rise in mesDA neuron markers. 
  
Coexpression of known dopaminergic genes in combination with Nato3 
 Coexpression of Otx2, Foxa2 and Lmx1a in combination with Nato3 does not 
produce an increase in Nurr1 relative to empty vector alone, as validated by both the ddCt 
method and REST analysis. Relative to empty vector, the Nurr1 expression fold change 
calculated by the ddCt method for Otx2+Nato3, Foxa2+Nato3 and Lmx1a+Nato3 was 
1.24, 1.31, and 1.03 respectively (Figure 10). Expression of Pitx3 is similar with a fold 
change of 1.19, 1.39, and 1.35 respectively (Figure 11). Finally, coexpression of Nato3 
with any of the other cofactors (Otx2, Foxa2 or Lmx1a) shows approximately a 50% 
decrease in TH (Figure 12). 
Since the fold change between chick midbrain expressing Nato3 alone and 
samples coexpressed with Nato3 and either Otx2, Lmx1a, or Foxa2 did not exhibit any 
sign that there was an increase in the levels of dopamine progenitor marker expression, 
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we suggest several possible explanations. The reason for our interest in these three genes, 
based on published literature, is that each should have generated an increase in the 
numbers of dopamine progenitors found in the midbrain. Otx2 is known to be required 
for mesDA development (Puelles et al., 2004), Lmx1a has been shown to increase the 
number of DA neurons when overexpressed (Andersson et al., 2006), and Foxa2 deletion 
has shown to be sufficient in diminishing the number TH positive cells (Ferri et al., 2007, 
Kittappa et al., 2007). The levels of TH in all conditions are less than the vector only 
control (pCIG) and may be due to the fact that TH does not start to appear until 110 hours 
post electroporation, and embryos were harvested at 72 hours. However, Nurr1 is present 
at this time point and since TH positive cells differentiate from Nurr1, we can use Nurr1 
as a lineage marker for what might occur at a later time period. It is also possible that we 
are increasing early dopamine neurogenesis and cells are either not mature enough or 
have arrest maturation and so we aren’t detecting more mature dopamine markers such as 
Pitx3 and TH. 
 
Determination of usable samples based on RNA integrity 
 Limited number of replicates can cause a data set to be of lower quality (Yuan et 
al., 2006), and so we decided to re-examine the effect of Nato3 overexpression by 
increasing our sample size. All samples expressing Nato3 and pCIG were also tested for 
the integrity of the RNA using a bioanalyzer in order to determine which samples should 
be used to continue experimentation. RNA is rapidly degraded into shorter fragments by 
RNase enzymes; potentially affect results of downstream applications (Imbeaud et al., 
2005). Along with quantifying the total RNA between 5-500ng/uL, the bioanalyzer also 
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allows for the comparison of samples using a RNA Integrity Number (RIN) to determine 
if degradation of the sample has occurred as well as if impurities are present (Schroeder 
et al., 2006). The RIN is generated through a proprietary algorithm that compares a 
variety of components and provides a range of 1-10, where 10 indicates the best RNA 
quality. The RIN uses the ratio of the area under the rRNA bands to the total area of RNA 
in the electropherogram, concentration of the sample, and the height comparison of the 
18S and 24S peaks generated by the software, where a ratio of 2:1 [28S:18S] indicates an 
intact sample. The height of the 28S band is especially important because it disappears 
faster than the 18S band and allows detection of beginning degradation (Shroeder et al., 
2006) All Nato3 and pCIG samples used in this experiment were of RIN numbers 6.2 and 
higher, with an average of 7.7. All samples used are considered to have acceptable RIN 
numbers (Shroeder et al., 2006). The total used number of samples provided an n=13 for 
Nato3 overexpression, and n=6 for pCIG vector only controls. 
 
Increase in sample sizes of Nato3 overexpression and control condition does not induce 
expression of dopamine lineage markers  
Once a verified quality sample set of overexpressed Nato3 (n=13) and pCIG 
(n=6) was obtained, we were interested in whether statistical significance for any of the 
markers of dopamine neurogenesis was upregulated further than in the original sample 
set. The three original samples for both Nato3 and pCIG were included in this extended 
sample set however fold change for all markers appear to decrease in the levels of 
expression detected (Figure 13-14). Figure 13 shows expression of Nurr1 for the 
comparison of Nato3 (n=3) and pCIG (n=3) to Nato3 (n=13) and pCIG (n=6). The 
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original sample size showed a fold change of 2.61 (ddCT) or 2.50 (REST) was observed; 
however, when the sample size was increased the fold change was only 1.24 (ddCt) or 
1.50 (REST). Results for Pitx3 were not able to be determine due to the fact that viability 
prevented us from increasing our sample size and the only samples that were run were the 
original n=3 (See Figure 6). TH expression decreased from 0.809 to approximately half 
the expression of the control at 0.585 fold change (Figure 14). Increase in sample size 
had no effect on Nurr1, Pitx3 or TH and significance was still not observed at p <0.05. 
What this demonstrates is that overexpression of Nato3 in the midbrain does not 
appear to increase the levels of Nurr1, TH, and Pitx3 at the time point harvested. As 
mentioned previously, TH does not appear until 110 hours post electroporation and so 
that particular result is not surprising. However, it was expected that there would be an 
increase in the levels of Nurr1 when Nato3 was overexpressed as stated in published 
research regarding Nurr1 role in mesDA development (Nunes et al., 2003) and our 
preliminary data. Based on the t-test for each marker, there is no statistically significant 
evidence for an increase in dopamine neurogenesis when Nato3 is overexpressed in the 
midbrain of the Gallus gallus embryo. The standard deviation for all markers in both 
Nato3 and control did not decrease as expected when the sample size was increased. 
Even more, the fold change had an apparent decrease. This change would indicate that 
there is not a correlation with Nato3 and dopamine neurogenesis. Similarly, the 
consistently large error leads us to believe that there may be an inconsistency in the 
methods being used and alternative experiments should validate this discrepancy to be 
certain (See Chapter 4). 
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Colocalization of Nato3 and Nurr1 
 An attempt was made to show colocalization of Nato3 and Nurr1 as well as Nato3 
and HNF3ß (Foxa2) through the technique of immunofluorescence. However, the degree 
of variability in the number of cDNA copies that we see between embryos made it 
difficult to show appropriate localization. The electroporation technique gives variability 
in the quantity of cells expressing EGFP as well as location along an anterior-posterior 
axis. Often EGFP could not be visualized, and when it could, it was not consistent 
enough to generate cell counts that could be used for a t-test in the same way that was 
used for qPCR.  Previous data (Kaufman and Taylor, unpublished data) have shown that 
EGFP expression, indicative of Nato3 expression is colocalized with Nurr1, but not 
exclusively (Figure 15). 
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CHAPTER III 
 
Discussion: Limitations and Future Aims 
 
Based on published data from Ono et al., 2010 and preliminary data from our lab 
stating that Nato3 is important for normal DA neuron formation we proposed that 
overexpression of Nato3 is sufficient to promote the expression of dopamine neuron 
markers in the posterior midbrain (caudal ventral midbrain) but not in any other region of 
the midbrain or neural tube based on immunofluorescence (Figure 15) (Kaufman and 
Taylor, unpublished) and in situ hybridization (Sarala Sarah and Merritt Taylor, 
unpublished data). Since this region of the brain is difficult to isolate due to the size of 
the embryo we decided to use qPCR as a fast screen method of the entire midbrain to see 
if certain dopamine expression markers are being up regulated when Nato3 is 
overexpressed in the midbrain. This method allowed for detection of expression not only 
in the posterior midbrain but the entire midbrain. Unfortunately, consistent and 
statistically significant results were unable to be obtained through this experiment.  
There may be a variety of reasons for obtaining such results. Most simply, the 
data may indicate that Nato3 does not promote dopamine neurogenesis, and the proposed 
pathway in Figure 2 is either incorrect or lacking more components than a single 
cofactor. However, there also seems to be a variety of technical limitations in Nato3 
expression that may still need to be solved. Finally, the negative results may be due to 
factors such as stage of development or the levels of induced expression. Overexpression 
of Nato3 occurs when exogenous expression of the gene occurs at a time and location 
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that it would not normally be. It may be possible that the time points at which we are able 
to harvest the embryo to attain viability may be preventing us from seeing the effects of 
Nato3 overexpression. It may also be that we are inducing either too much or too little 
expression and that there is a concentration effect on cell fate. Shh, for example, can 
cause either repression or induction of a gene simply through the concentration and 
duration of expression (Joksimovic et al., 2009). Another example is when different 
combinations of proneural bHLH factors such as Ngn and Mash1 are combined with 
different patterning factors such as Olig2, Pax6 of Nkx2.2. Varying combinations can 
induce production of different cell types such as neurons, oligodendrocytes and astrocytes 
at different locations or at different time points (Guillemot 2007, Sugimori et al., 2007). 
Thus, cellular response to a particular factor may have an alternative effect when the 
factor is presented at different concentrations and/or time points. If this is true, Nato3 
may be necessary, but not sufficient to drive dopamine neurogenesis unless it is 
expressed at the necessary concentration and duration with the appropriate cofactors. 
Despite these results, the degree of error shown in all qPCR analyses may be directed to 
an inconsistency in the system used and experiments that could validate this discrepancy 
as well as improve the system are discussed below. 
 
Limitations of the Electroporation technique 
 After obtaining results for this investigation, it was clear that there is a large 
degree of variability within the samples, shown by the standard deviation. Given that the 
handling of the samples post electroporation were very similar, this led to the idea that 
inconsistency and variation comes during the electroporation process. There is typically 
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an 80% viability of embryos; however, the localization of where the DNA is inserted and 
the efficiency of the DNA being taken into the cells can be variable simply due to human 
error. In addition, given published literature regarding the mechanism of Nato3 and its 
involvement in the regulation and generation of mesDA neurons, the result that there is 
no significant difference between overexpression of Nato3 and pCIG was unexpected. 
The large degree of variability made it difficult to determine whether or not our results 
were real or if there was a potential problem with various techniques and components 
being used throughout this investigation. Data collected by others in the lab (Peterson and 
Taylor) indicate variability in Nato3 expression between samples, although strict 
correlation with the amount of Nato3 overexpression and Nurr1 expression was not 
observed. I would recommend exploring various areas to try and improve the techniques 
used and decrease the levels of variability in the current system.  
Aims: To improve current system 
 In the coexpression system, Nato3 and each cofactor were located on different 
vectors when introduced into the system. This may allow for unexpected toxicity due to 
competition of the vectors or overloading the system. Placing both genes on the same 
plasmid could be accomplished by generating them on a two-promoter plasmid. Each 
transcript would then be generated independently of the other (Kim et al., 2004)
 Variability at the mRNA level was a problem seen throughout many points of this 
experiment. This may have occurred as early as during vector design and cloning. The 
pCIG vector being used as the control (Figure 3A), as well as the backbone for our Nato3 
and cofactor constructs are located on a bicistronic EGFP vector containing an IRES 
(Internal Ribosome Entry Site). This was designed so that the expression of protein could 
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be expressed and monitored using EGFP in this case. However, IRES-controlled 
expression has been determined to result in a 10-fold difference in expression between 
the two genes (Kim et al., 2004, Martin et al., 2006). In order to facilitate cloning into the 
IRES-controlled cDNA and to ensure that the initiation codon would be located in the 
inserted coding sequence, the AUG was modified to a HindIII site. However, this 
insertion dropped the level of expression of the second cistron to levels often difficult to 
detect (Martin et al., 2006). Considering that there could be a difference in the level of 
mRNA generated by the plasmid and the amount of EGFP expression seen under the 
scope, it may be plausible that the current vector may not allow for the adequate 
production of EGFP, which allows us to visualize the transfection efficiency of the Nato3 
gene using immunofluorescence. A vector has since been developed that does not alter 
this IRES, which allows for stronger EGFP expression, includes the ability for 
bidirectional cloning, N-term HA-tagging for protein monitoring, easy sequencing, and 
can produce retroviral particles if needed (pPRIG; Albagli-Curiel et al., 2007). 
 In addition to improving detection of the transfection efficiency and analysis of 
the gene overexpression, there may be a better way to detect using qPCR. When this 
project was designed, funding was taken into consideration and so SYBR green was the 
method chosen for qPCR analysis because probes are not required, which decreases the 
running costs in comparison to TaqMan® (Life Technologies); however, particular 
problems encountered may make TaqMan® a more appealing option. Specifically, SYBR 
green dye binds to any double stranded DNA, including non-specific double stranded 
DNA resulting in false positives. Although SYBR green false positives can be checked 
by looking at the dissociation curves and running the product out on a gel, the use of 
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probes would reduce background and false positives because they are able to generate 
signal from the actual event of the probe binding to the template DNA. This event allows 
for the detection of two distinct sequences within one reaction tube. The use of this assay, 
if even on a small set of data points, may clear up discrepancies of false positives 
occurring, whether in the housekeeping gene or our samples and allow for a greater 
detection of small fold differences that could present. 
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CHAPTER IV 
 
Discussion: The use of the RCAS retroviral system 
 
Background of RCAS 
Another approach to improve the expression of the Nato3 gene may lie with the 
use of a retroviral expression system that relies on integrating the gene of interest into the 
genome of the target cell. Many retroviruses lose all or part of essential viral genes as a 
consequence of acquiring oncogenes from the host cell, making them replication-
defective unless proteins that encode for the missing gene are supplied by a helper virus 
or an endogenous virus carried by the host cell. (Hughes et al., 1987, Hughes 2004). By 
acquiring an src oncogene, which regulates embryonic development and cell growth, 
Rous sarcoma virus (RSV) retained sequences that were essential for replication but did 
not lose any viral properties, making it the only known retrovirus to be replication 
competent. (Hughes et al., 1987, Hughes 2004).   
Avian leukosis-sarcoma viruses (ALSV) are a family of viruses that include 
(ALVs), Rous sarcoma virus (RSV), and Replication-Competent ASLV long terminal 
repeat with a Splice acceptor (RCAS) (Hughes 2004). Since RCAS vectors are derived 
from ASLV viruses, they too are replication competent in avian cells (Hughes 2004). 
The chick as a model system has always had a classic role in studying 
embryology due to its low cost, ease of manipulation at multiple time frames of 
development (Logan 1998, Hughes 2004). Avian retroviruses have thus become a 
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prevailing experimental tool since other genetic approaches such as transgenic and 
knockout systems are not currently available in the chick (Logan et al., 1998).  
When genes are inserted into RCAS vectors they are expressed from the long 
terminal repeats (LTR) promoter, and so the level of expression of the insert thus depends 
on the expression of the enhancer within the LTR as well as the pol gene (Hughes 2004). 
Through substituting the pol gene with a particular strain of RSV known as “Bryan high-
titer strain,” a new strain known as RCASBP (RCAS Bryan Polymerase) was created 
with a 5-10 fold increase in the LTR promoter expression  (Hughes 2004). Within this 
new strain there are subgroups that refer to the envelope subtypes defined by the receptor 
protein that it interacts with on the host cell (Logan et al., 1998). Two subtypes that are 
commonly used in laboratory research are RCASBP(A) and RCASBP(B). Subgroup B 
was found to yield a three-fold increase than subgroup A in virus expression within the 
CNS, and even higher when coupled with polybrene (Hermann et al., 2003). RCASBP(B) 
was also found to induce more widespread expression than RCASBP(A) (Smith et al., 
2009), however, the subgroup A receptor has been identified whereas subgroup B has not 
(Logan et al., 1998). 
One of the pitfalls to the RCAS system is the large size of the induction vector 
(~11.6kb), limiting the insert size to ~2.4-2.6kb (C.Cepko, reported by Logan et al., 
1998) and only three restriction enzyme sites for inserting a gene (Loftus et al., 2001). 
Due to this restriction, further attempts to ease the use of the RCAS retroviral system 
were made by designing modified versions that are compatible with the Gateway System 
(Invitrogen). These vectors include RCASBP-Y DV, and two that contain either a C-term 
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or N-term HA epitope tag, RCASBP-Y CHA and RCASBP-Y NHA respectively (Loftus 
et al., 2001). 
 
Background of Preliminary experimentation 
 An attempt to use the RCAS retroviral vector was made by an individual in the 
lab (Michael Wilson) as an undergraduate independent research project. Important 
headway was made when he was able to construct an RCAS-Nato3 and RCAS-GFP 
using G-RCAS (addgene) and the Gateway Cloning system (Invitrogen). Once the 
RCAS-Nato3 and RCAS-GFP virus was constructed and sequenced, it was electroporated 
into the neural tube of the chick embryo. Results showed that although the virus was 
being overexpressed, the expression was limited to particular areas of the midbrain as 
opposed to broad expression typical of retroviruses. The goal was to generate and harvest 
live Nato3 retrovirus in cell culture in order to get a high titer virus stock. Problems arose 
when expression was not observed in the RCAS-GFP control and the virus stock was of a 
low concentration. The project ended and RCAS-Nato3 was not further explored. The 
concept of this project has great potential and due to the retroviral properties should be 
considered in further attempts. The following provides a method for improving the 
system in order to answer our original question of the role of Nato3 in the regulation and 
development of mesDA neurons. 
 
Cloning into the RCAS retroviral system 
Due to the ease of the Gateway System and the availability of various RCAS 
vectors from Addgene, there are multiple ways to proceed. The design of RCASBP-Y 
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DV (addgene: 11478), RCASBP-Y CHA (addgene: 11480), and RCASBP-Y NHA 
(addgene: 11479) allow for multiple options. I would begin by choosing one of the 
vectors containing the HA-epitope tag because it would allow for the rapid determination 
of cellular localization (Loftus et al., 2001). This would be a useful tool since Nato3 and 
EGFP cannot both be inserted to the viral vector due to size constraints. The Gateway 
system would then be the appropriate way to create a construct containing Nato3 (will be 
referred to as RCASBP-HA-Nato3 (Figure 16), representing the choice of epitope tag). I 
would also use a control for adding the epitope tag and use Nato3 without the tag in this 
system to make sure that the addition of the tag would not disrupt the function. 
 
Propagation of RCASBP-HA-Nato3 
 The CEF (chicken embryo fibroblast) cell line is frequently used in 
experimentation, including previous research done on this virus construct, because it can 
be generated from stage 36 chick embryos (Logan et al., 1998). I would suggest using the 
DF-1 cell line (ATCC #. CRL-12203) to propagate the RCASBP-HA-Nato3 virus. It is an 
immortal cell line derived from CEF, however it is found to have a 35% better 
transfection efficiency than CEF (Lee et al., 2008) and provide a titer approximately 2-
fold higher (Schaefer-Klein et al., 1998, Seidler et al., 2008). Through combination of 
various published protocols, and my experience, I would make the following 
modifications to the protocol for virus production. 
For transfection of the induction vectors, Superfect (Qiagen) has been found to 
give the most reproducible and highest transfection efficiency on DF-1 cells as compared 
to CaCl2 and Lipofectamine Plus (Gibco) (Chen et al., 1999). Lipofectamine 2000 (Life 
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Technologies) has also been proposed to work well in methods used by Smith et al., 
(2009) for propagation of the virus and concentration of the active virus. A viral stock 
less than 5x107 IU/ mL is not considered to be useful for high efficiency injection of the 
neural tube (Bronner-Fraser et al., 1996) and a titer between there and 108 IU/ mL should 
be obtained for optimal results (Seidler et al., 2008).  
 Once the virus is collected it can be injected into the neural tube of the chick 
embryo. Published results have indicated that viral injection at (Hamburger and 
Hamilton) HH10 (Figure 1A) produce an 80-90% survival, HH4/5 a 20% survival, and 
no survival at HH3 (Bronner-Fraser et al., 1996). Stage HH7-8 has also been used with 
success (Hermann et al., 2003). The technical aspects of the electroporation should also 
be altered to accommodate the viral nature. To increase the transduction efficiency, 
80ug/mL of polybrene can be added to the viral supernatant with only 0.1% fast green for 
visualization. An alternative approach is to electroporate the viral proDNA in the 
midbrain. In this case, more, higher voltage pulses over a shorter period of time (10x20-
25V pulses applied over 25ms), is recommended in comparison to the current method 
(5x16V pulses, 50ms in length, 1 second intervals between pulses) that we use with 
pCIG. However, this method has been shown to promote ectopic expression of some 
regionally restricted neural markers, and so careful negative controls would need to be 
employed (Hermann et al., 2003). 
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Troubleshooting 
 If it is still difficult to generate a high titer stock of the virus, RCANBP can be 
used as a control. RCANBP is essentially identical to RCASBP but it does not have an 
src splice acceptor in front of the inserted gene, and as a consequence will not produce 
the smaller spliced message (Hughes et al., 2004). Therefore, if a high titer virus cannot 
be made with the RCANBP vector, it may be an indication that the DNA sequence is 
interfering with the production of the virus or that the construct may be toxic if producing 
a rate of mortality greater than 10% in ovo (Logan et al., 1998). Modifications could also 
be made to how the DNA is generated by using an endotoxin-free proviral DNA (such as 
Qiagen EndoFree maxi kit), which may increase the transfection efficiency (Smith et al., 
2009).  
 
Expected outcomes 
 A variety of alterations, designed to increase the efficiency and decrease the 
variability of this experiment, were made a various levels. I would expect that we would 
get a clear answer as to whether or not Nato3 is sufficient to give rise to mesDA neurons 
when overexpressed in the midbrain of the Gallus gallus embryo. If our hypothesis is 
correct, then we would expect to see a greater expression of DA lineage markers with 
Nato3 overexpression because sustained Hes1 represses the cell cycle (Ono et al., 2010). 
Also, since Nato3 represses Hes1 expression, it is possible that we may see a greater 
amount of proliferation (measured by detection of Ki67 expression, a marker for cellular 
proliferation). Given that Nato3 is known to repress Hes1 in the ventral midbrain, 
detecting expression of Hes1 using qPCR in the Nato3 overexpressed condition may also 
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give insight into what is happening to Hes1 when Nato3 is overexpressed. However, it 
should be noted that because ventral midbrain levels of Hes1 are already low, we may not 
be able to detect the suppression of Hes1 in this region when Nato3 is overexpressed. 
Along with Hes1, we could also look for upregulation of proneural gene expression (i.e. 
Ngn2, Asc1) since repression of Hes1 by Nato3 is known to give rise to expression of 
these proneural genes. Furthermore, if these changes in our methods decrease the 
observed variability, our hypothesis may not be correct and Nato3 may not be sufficient 
to promote a dopamine neuron lineage. Monitoring the levels of other neural lineages 
when Nato3 or other dopaminergic genes (Otx2, Foxa2, Lmx1a) are overexpressed may 
give insight as to what these genes are doing. For example, they may not be driving a 
dopamine specific lineage, but possibly driving expression of other neuronal markers. 
These markers may include Helt (a ventral midbrain neural progenitor marker), Brn3A (a 
motorneuron marker), or GABA, Glutamate, and Seratonin (neuronal subtype markers).  
It is also possible that Nato3 could drive glial lineages such as oligodendrocytes (Olig2) 
or astrocytes (GFAP). With better expression and methods of detection, it may be 
possible to determine the role of Nato3 to drive dopamine neurogenesis.  
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CHAPTER V 
 
Methods 
 
Cloning of genes used for Electroporation 
 The open reading frames of Nato3, Lmx1a, Foxa2 and Otx2 have been cloned 
from a mouse embryonic cDNA library and subcloned into a bicistronic vector backbone 
(pCIG) that expresses the gene of interest and EGFP in Gallus gallus embryo (Figure 
3A).  This allowed us to express Nato3, Lmx1a, Foxa2, and Otx2 either alone or in 
combination, through the use of in ovo electroporation. 
 
In ovo Electroporation 
Expression of Nato3, Lmx1a, Foxa2, and Otx2 either alone or in combination, 
was accomplished through the use of in ovo electroporation into the midbrain of HH 
stage 10–12 (Hamburger et al., 1951) chick embryos (Figure 1A) (Kaufman unpublished 
data, Nakamura et al., 2004). Fast green was used for visualization of transfection 
mixture that included expression vectors (0.5ug/ul for each expression vector pCIG, in 
addition to non-coding DNA pBluescript vector brought to a final DNA concentration of 
3ug/ul) as it was microinjected into the lumen of the developing midbrain. To transfect 
the embryonic tissue with the expression vector(s), rapid, brief electric pulses (five 16V 
pulses that are 50ms in length applied with 1 second intervals between pulses) were 
applied by an electroporation generator (BTX ECM 830, Harvard Apparatus, Holliston 
MA) through platinum electrodes constructed for this purpose (Krull, 2004) and placed 
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on either side of the embryonic midbrain (Nakamura et al., 2004).  Embryos were 
allowed to continue development by incubation at 100°F and harvested after 72 hours to 
create a cDNA library for qPCR analysis (see Midbrain mRNA expression below) or 
sectioned into 10µM sections and used for immunofluorescence (see 
Immunofluorescence below). 
 
Primer design for qPCR analysis 
All primers (Integrated DNA Technologies (IDT) Coralville, IA) were designed 
against the Gallus gallus β-actin, Nurr1, TH, and Pitx3 open reading frames (Table 1) 
using DNAStar (Lasergene) and Primer-Selection (Lasergene) to check for primer dimers 
and hairpin structures. SYBR Green fluorescent dye was used to bind specifically to the 
minor grooves of double stranded DNA (Morrison, et al., 1998)) so that the mRNA levels 
of Nurr1, TH, and Pitx3 could be measured with real-time quantitative PCR using the 
MX3000P Real-Time PCR system (Stratagene). Data output was compiled using MxPro 
software and analyzed by comparing the difference between target (Nurr1, TH, Pitx3) 
and endogenous control (β-actin) cycle thresholds using two different comparative Ct 
methods, including the ddCt method (Livak and Schmittgen, 2001) and the REST method 
(Pfaffl et al., 2002) expressed as fold difference from the control group. 
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Table 1: Primers designed for qPCR analysis of avian (Gallus gallus) gene expression 
Gene  
Direction of 
Primer 
Primer sequence 
(5’-3’) 
Melting 
Temperature 
(Tm°C) 
GC% 
Forward  GCTACAGCTTCACCACCACA 57.5 55 
Β-actin 
Reverse  TCTCCTGCTCGAAATCCAGT 55.7 50 
Forward  ACGACACTCAGCACATCCAG 57.2 55 
Nurr1 
Reverse  ACCCCATTGCAGAAGATGAG 54.9 50 
Forward  CAATGAGACAACATCCCCC 53.6 50 
TH 
Reverse  CGTGGCGGATATACTGTGTG 55.5 55 
Forward  CAGCACGCCAACTTCACTTA 55.6 50 
Pitx3 
Reverse  GGTGGGGAAAGACAGTCAAA 55.0 50 
 
Midbrain mRNA expression 
Embryonic midbrain was inspected for EGFP expression under dissecting 
microscope and isolated, homogenized in Trizol reagent (Invitrogen, Carlsbad CA) and 
stored at -80°C. Total RNA was isolated and eluted according to the manufacturer's 
instructions (RNeasy Lipid Tissue Mini Kit, Cat # 74104, Qiagen, Valencia, CA) within 
one month of harvesting. RNA was quantified using a Nanodrop instrument. RNA quality 
was determined using an Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, 
CA, USA). cDNA was prepared from total RNA using a high-capacity cDNA Reverse 
Transcription Kit (Applied Biosystems Cat # 4368814, Carlsbad, CA). A 1:10 dilution of 
the cDNA library was then used for a working stock for quantitative PCR. GoTaq® 
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qPCR Master Mix (Promega, Cat # TM318, Madison, WI) was used and all reactions 
were measured in triplicate, dispensed into 96-well reaction plates (USAScientific: 96 
well plates Cat # 1402-9596, TempPlate Sealing film Cat #2921-0000).  
Statistical analysis 
The mRNA expression was evaluated using two common methods to generate a 
comparison.  To account for differences in mass of the tissue, a normalizing gene like β-
actin is measured in all samples. During amplification, the double stranded DNA product 
from the PCR reaction fluoresces in the presence of the nuclear binding dye SYBR green. 
When amplification becomes exponential and crosses the baseline, this is considered the 
“crossing threshold” value, or Ct value. Likewise, the Ct value for a target gene, like 
Nurr1, can be determined as well. In Figure 5A, for example, the average Ct values of 
Nurr1 and β-actin are calculated as well as the standard deviation for each Ct 
calculations. The ddCt method provides a way to calculate fold change and standard 
deviation using propagation of error of the dCt (the average Ct of Nurr1 minus the 
average Ct of β-actin) while also assuming that the primer efficiency of the reference 
gene is equal to that of the target gene (Livak et al., 2001, Yuan et al., 2006). SPSS 
software (IBM, V.20) was also used to evaluate pairwise comparisons made using a two-
sample equal variance (homoscedastic) test, (2-tail, α = 0.05) and 95% confidence 
intervals. The second method is using Pfaffl’s REST© (Relative expression software 
tool; see Figure 5B), which accounts for primer efficiencies less than 100% and also 
calculates fold change, standard error, confidence interval, and significance value at p 
<0.05 (Pfaffl, 2001, Pfaffl et al., 2002). The software designed compares the Ct values of 
a test group by randomly matching them with the Ct values of a control group. The 
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difference between the ddCt method and Pfaffl’s method of REST analysis is not only the 
inclusion of primer efficiency, but also that the Ct of the target gene (Nurr1) for the 
negative control (pCIG) is subtracted from Nurr1 Ct of the experimental condition 
(“sample” or Nato3) (Figure 5A) before being normalized to the difference in β-actin Ct 
(compare “Target ΔCP” vs “Reference ΔCP” in Figure 5B). Pairwise comparison of the 
dCT of different replicates was done repeatedly (2000 times) in order to test for 
significance and generate an estimation of error (SEM) (Pfaffl et al., 2002). 
In order to use a t-test to analyze the data, descriptive statistics including 
skewness coefficient was used to determine that the data fit a normal distribution and that 
they will have equal variances (Yuan et al., 2006). However, with such a small sample 
size, our formal tests do not have enough power to appropriately determine equal 
variances, and a distribution-free Wilcoxon test is considered a more robust test (Yuan et 
al., 2006). The concern about the application of the t-test or Wilcoxon test differs within 
the scientific community, and many biological phenomena with limited number of 
replicates are treated with a t-test, even though normal distribution may not formally be 
able to be tested (Yuan et al., 2006).   
 
Immunofluorescence 
Select embryos with favorable EGFP expression were used for 
immunofluorescence in order to visually detect protein expression by fixing the embryos 
for 1 hour in paraformaldehyde (Sigma, Cat # 158127, St. Louis, MO), followed by 
 35 
embedding in Cryo-OCT (VWR, Cat # 25608-930, Radnor PA) and sectioning of the 
tissue into 10um thick sections as described (Taylor et al., 2007).  
In order to detect expression of DA neuron and floor plate markers in cells, we 
used antibodies directed against DA neuron/floor plate lineage markers, including Nurr1 
(1:200, Cat # E0908, Santa Cruz Biotechnology, Inc.) and Foxa2 (1:100, Cat # MAB5280 
Millipore, Temecula, CA) respectively.  Nato3 expression in electroporated regions of the 
midbrain will be identified by the reporter gene EGFP expression, located in the 
bicistronic pCIG vector with the gene of interest.  Photomicrographs (Olympus BX51 
upright scope, Retiga 1300 camera, QCapture version 2.66.4 software) were taken of the 
regions of overexpression that have been treated to identify coexpression of markers for 
Nato3 vector expression (EGFP 1:200, Abcam Inc.) and DA/floor plate markers 
(Nurr1/Foxa2).  Ectopic expression of the DA markers that are dependent upon the 
“Nato3 + cofactor” conditions were determined by identifying colocalization of EGFP 
with DA markers Nurr1 and/or TH.  
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Figure 1: Models of cell lineage. (A) Depiction of the anatomical position of the floor 
plate region in the neural tube. Dopamine (DA) neuron progenitors arise from a specific 
region along the ventral midline of the midbrain known as the floor plate (See Figure 1A 
left). A cross-section of the neural tube is shown with the morphogen Shh, which is 
released from the notochord to induce floor plate cell differentiation (See Figure 1A 
right). Although the floor plate extends from the forebrain to the spinal cord, it is only 
competent to give rise to dopamine neurons in the midbrain. (B) Model of dopamine 
lineage maturation. In this specific pathway, floor plate cells have the ability to generate 
dopamine progenitors, which will then progress through a differentiation process into a 
mature dopamine neuron. Arrow indicates at which stage of the lineage that each marker 
used in this study are present.  
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Figure 2: Current Model for the regulation of neurogenic activity in mesFP cells (A) 
Repression of Hes1 via Nato3 to repress cell cycle arrest is based on published results 
from Ono et al., (2010). (B) Proposed theory for promoting a dopamine specific lineage 
through Nato3 and other possible cofactors known for their roles in the promotion of 
mesFP cells to mesDA neurons.  
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Figure 3:  The bicistronic pCIG-EGFP vector. The pCIG vector derived from the 
pCAGGS vector by the McMahon lab (Meganson and McMahon, 2002) by slightly 
altering the multiple cloning site (MCS) and the addition of nuclear localization 
sequences in the EGFP (Niwa et al., 1991). The vector was used as the expression vector 
for Nato3, Otx2, Foxa2 or Lmx1a, and also as the control. 
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Figure 4: Determination of qPCR efficiencies of reference gene (β-actin) and target 
genes (Nurr1, Pitx3, and TH). Efficiency of primers was tested prior to use with 
experimental cDNA. Efficiency = 10^ (-1/slope)-1 where slope should be within -3.10 to 
-3.59. (A) Efficiency of ß-actin calculated to be 81%. (B) Efficiency of Nurr1 calculated 
to be 97.6%. (C) Efficiency of TH calculated to be 143%. (D) Efficiency of Pitx3 
calculated to be 103%. “Ct” refers to the cycle number where amplification is first 
detected by the qPCR machine (aka: the crossing threshold). 
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Figure 5: Outline of two methods for the calculation of fold change for gene expression. 
(A) Flow chart demonstrating how fold change is calculated using the ddCt method. (B) 
Fold change calculation presented by Pfaffl et al., (2002) and used by “REST” software 
analysis.  
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Figure 6: Effect of Nato3 overexpression on dopamine neurogenesis. Expression of each 
marker compares overexpression of Nato3 to the empty vector (pCIG) in the midbrain of 
the Gallus gallus embryo. The effect of overexpression is demonstrated by a fold change 
with ±SD for the ddCt method. When indicated (“REST”) REST analysis is shown with 
SE. n=3 for all samples, and no significance was determined at p<0.05. (A) Comparison 
of the ddCt method for pCIG and Nato3 is made to (B) the REST analysis of Nato3 for 
the immature dopamine marker Nurr1. (C) A 1.29 fold increase was observed for the 
marker Pitx3 compared to the control. (D) A decrease of 0.19 was observed in the mature 
DA marker TH, resulting in a fold change of 0.81. 
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Figure 7: Comparison of two analysis approaches on the effect of overexpression of 
various known dopaminergic genes on Nurr1 expression in the developing Gallus gallus 
embryonic midbrain. (A) The table lists the fold change, standard deviation for the ddCt 
method and standard error for the REST analysis, P-value and confidence interval based 
on ddCt or REST. Analysis includes Otx2, Foxa2, Lmx1a, Nato3 and pCIG (n=3) 
expression conditions. The effect of overexpression is demonstrated by a fold change 
with ±SD for the ddCt method and ±SE for REST analysis. (B) There is no significant 
fold increase of Nurr1 when using the ddCt method for Otx2, Foxa2 or Lmx1a. (C) 
Results of the REST analysis for Nurr1 are similar to the ddCT method for all factors 
(note: pCIG for REST analysis does not yield SE). 
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Figure 8: Effect of gene overexpression on Pitx3 mRNA in the Gallus gallus embryonic 
midbrain. (A, B) Statistical analysis of Otx2, Foxa2 and Lmx1a overexpression are 
shown in comparison to the control using the standard ddCt method. The effect of 
overexpression is demonstrated by a fold change with ±SD, n=3. Significance was 
determined at *p<0.037 for Pitx3 when Foxa2 was overexpressed. (C) Results of the non-
parametric Wilcoxon Signed Ranks test confirming significant results for an increase in 
fold change when Foxa2 is overexpressed at p<0.05. 
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Figure 9: Effect of gene overexpression on TH mRNA. (A, B) Statistical analysis of 
Nato3, Otx2, Foxa2 and Lmx1a overexpression are shown in comparison to the control 
using the standard ddCt method. The effect of overexpression is demonstrated by a fold 
change with ±SD, n=3. A decrease in fold ranging from 0.603 to 0.811 was observed for 
all conditions in comparison to the control. 
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Figure 10: Comparison of two analysis approaches on the effect of Nurr1 production 
when various known dopaminergic genes are coexpressed with Nato3. (A) The table lists 
the fold change, standard deviation for the ddCt method and standard error for the REST 
analysis, P-value and confidence interval derived from either REST or SPSS. Sample set 
includes Otx2, Foxa2, Lmx1a, Nato3 and pCIG (n=3). Expression is in comparison to the 
pCIG control vector when overexpressed in the midbrain of the Gallus gallus embryo. 
The effect of overexpression is demonstrated by a fold change with ±SD for the ddCt 
method and ±SE for REST analysis. (B) There is no significant fold increase of Nurr1 
when using the ddCt method. (C) Results of the REST analysis for Nurr1 are similar to 
the ddCT method.  
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Figure 11: Coexpression of Nato3 and known dopaminergic genes does not cause an 
increase in Pitx3 mRNA expression in the Gallus gallus embryonic midbrain. (A, B) 
Statistical analysis of Otx2, Foxa2 and Lmx1a overexpression in combination with Nato3 
are shown in comparison to the control using the standard ddCt method. The effect of 
overexpression is demonstrated by a fold change with ±SD, n=3. Significance was not 
demonstrated for any condition at p <0.05. 
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Figure 12: Coexpression of Nato3 and known dopaminergic genes does not cause an 
increase in TH mRNA expression in the Gallus gallus embryonic midbrain. (A, B) 
Statistical analysis of Otx2, Foxa2 and Lmx1a overexpression in combination with Nato3 
are shown in comparison to the control using the standard ddCt method. The effect of 
overexpression is demonstrated by a fold change with ±SD, n=3. All conditions showed a 
trend toward down regulation of DA lineage markers but significance was not 
demonstrated at p <0.05. 
 
  
 58 
 
 
Figure 13: Increasing sample size does not reveal a change in Nurr1 mRNA expression 
with Nato3 overexpression in the Gallus gallus embryonic midbrain. (A) The table lists 
the fold change, standard deviation for the ddCt method and standard error for the REST 
analysis, P-value and confidence interval derived from either REST or SPSS. Sample set 
includes Nato3 and pCIG at different sample sizes. Expression is in comparison to the 
pCIG control vector when overexpressed in the midbrain of the Gallus gallus embryo. 
The effect of overexpression is demonstrated by a fold change with ±SD for the ddCt 
method and SE for REST analysis. (B) There is no significant fold increase of Nurr1 
when using the ddCt method. (C) A decrease in fold change of Nurr1 expression is seen 
when the sample set is increased (Nato3 n=13, pCIG n=6) in comparison to the original 
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set (Nato3 n=3, pCIG n=3) using REST analysis. These results are comparable to the 
results using the ddCt method in Figure B.  
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Figure 14: Overexpression of Nato3 does not cause upregulation of TH mRNA 
expression in the Gallus gallus embryonic midbrain. (A, B) Statistical analysis of varying 
sample sizes of Nato3 is in comparison to the varying sample sizes of the control using 
the standard ddCt method. The effect of overexpression is demonstrated by a fold change 
with ±SD. Nato3 (n=3) is compared to pCIG (n=3) and Nato3 (n=13) is compared to 
pCIG (n=6). Significance was not determined at p<0.05. 
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Figure 15: Immunofluorescent colocalization of Nato3 overexpression and Nurr1. (A) 
The control is the unelectroporated side of the midbrain showing Nato3 misexpression 
(EGFP) and Nurr1 expression (red). Overlay of Nato3 overexpression and Nurr1 
expression; yellow demonstrates colocalization. (B) Magnification of Nato3 
overexpression (green), Nurr1 expression (red), and colocalization of Nato3 and Nurr1 
(yellow). Arrow indicates one example of overlapping expression. 
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Figure 16: Diagram of RCASBP HA-Nato3 retroviral plasmid. Nato3 would be added to 
the RCASBP-histone tagged plasmid using the Gateway system (Invitrogen). 
 
 
 
